IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,398 | -61.4% | 13,437 | -57.9% | 0.02% | -47.8% |
| Q1 2023 | $335,514 | -34.1% | 31,893 | -22.4% | 0.05% | -36.1% |
| Q4 2022 | $509,068 | +224.2% | 41,087 | +205.3% | 0.07% | +620.0% |
| Q4 2021 | $157,000 | -25.9% | 13,458 | -34.6% | 0.01% | -63.0% |
| Q2 2020 | $212,000 | -69.3% | 20,581 | -69.9% | 0.03% | -70.7% |
| Q1 2020 | $690,000 | -38.8% | 68,418 | -19.2% | 0.09% | -50.8% |
| Q4 2019 | $1,128,000 | – | 84,726 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |